Morgan Stanley’s Cognition Therapeutics CGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2K Sell
27,873
-65,455
-70% -$76.2K ﹤0.01% 6704
2025
Q4
$126K Buy
93,328
+60,638
+185% +$98.4K ﹤0.01% 6105
2025
Q3
$44.1K Buy
32,690
+1,621
+5% +$2.21K ﹤0.01% 6453
2025
Q2
$9.63K Hold
31,069
﹤0.01% 6867
2025
Q1
$13.1K Buy
31,069
+14,196
+84% +$8.34K ﹤0.01% 6723
2024
Q4
$11.8K Buy
16,873
+15,873
+1,587% +$7.85K ﹤0.01% 6744
2024
Q3
$469 Sell
1,000
-2,000
-67% -$2.06K ﹤0.01% 7307
2024
Q2
$4.98K Hold
3,000
﹤0.01% 6852
2024
Q1
$5.46K Sell
3,000
-40,738
-93% -$84.1K ﹤0.01% 6871
2023
Q4
$80.9K Buy
43,738
+21,869
+100% +$28.9K ﹤0.01% 6229
2023
Q3
$31.5K Hold
21,869
﹤0.01% 6334
2023
Q2
$40K Hold
21,869
﹤0.01% 6307
2023
Q1
$43.3K Hold
21,869
﹤0.01% 6334
2022
Q4
$45.9K Hold
21,869
﹤0.01% 6332
2022
Q3
$42K Hold
21,869
﹤0.01% 6475
2022
Q2
$46K Buy
+21,869
New +$56.5K ﹤0.01% 6648

Other funds holding CGTX